Venous thromboembolism and atherothrombosis an integrated approach

G Piazza, SZ Goldhaber - Circulation, 2010 - Am Heart Assoc
2146 female Nurses' Health Study, obesity tripled the risk of unprovoked PE. 7 Hypertension
predisposes to both atherothrombosis and VTE. Hypertension is associated with a 50 …

Hypercoagulable states

JAM Anderson, JI Weitz - Clinics in chest medicine, 2010 - chestmed.theclinics.com
Arterial thrombosis and venous thrombosis are common problems facing clinicians. Some
patients with thrombosis have an underlying hypercoagulable state. These states can be …

Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies

S Shapiro, J Dinger - BMJ Sexual & Reproductive Health, 2010 - srh.bmj.com
Background Two recent studies, a cohort study from Denmark, and a case-control study from
The Netherlands, have reported increased risks of venous thromboembolism (VTE) among …

Acute pulmonary embolism

PD Stein, F Matta - Current problems in cardiology, 2010 - Elsevier
Most large or fatal pulmonary embolisms (PE) at autopsy were unsuspected ante mortem.
Newly identified clinical characteristics of PE enhance our ability to identify potential …

Clinic versus over-the-counter access to oral contraception: choices women make along the US–Mexico border

JE Potter, K White, K Hopkins… - … journal of public …, 2010 - ajph.aphapublications.org
Objectives. As part of the Border Contraceptive Access Study, we interviewed oral
contraceptive (OC) users living in El Paso, Texas, to assess motivations for patronizing a US …

Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy

MT DeSancho, T Dorff, JH Rand - Blood Coagulation & …, 2010 - journals.lww.com
Thrombophilia contributes to the risk of thrombosis in women using female hormones. The
objective of the present study was to evaluate the prevalence of thrombophilia in women …

Protrhombotic effects of contraceptives

G Fazio, F Ferrara… - Current …, 2010 - ingentaconnect.com
The use of oral contraceptives first became widespread some 40 years ago, and reports of
an excess risk of cardiovascular disease among women who used these agents soon …

The antithrombotic effect of the aminoestrogen prolame (N-(3-hydroxy-1, 3, 5 (10)-estratrien-17B-YL)-3-hydroxypropylamine) is linked to an increase in nitric oxide …

G González, N Alvarado-Vasquez, JM Fernández-G… - Atherosclerosis, 2010 - Elsevier
OBJECTIVE: Women under hormone replacement therapy carry an increased risk of venous
thromboembolism (VTE), mostly during the first year. Despite great efforts devoted to …

Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24 …

C Brucker, B Hedon, HS The, K Höschen, N Binder… - Contraception, 2010 - Elsevier
OBJECTIVE: This study was conducted to assess the long-term efficacy and safety of a low-
dose monophasic combined oral contraceptive (COC) containing 0.02 mg ethinylestradiol …

Associations between high factor VIII and low free protein S levels with traditional arterial thrombotic risk factors and their risk on arterial thrombosis: results from a …

R Mulder, IM van Schouwenburg, BK Mahmoodi… - Thrombosis research, 2010 - Elsevier
INTRODUCTION: Whether high factor (F) VIII and low free protein S levels are risk factors for
arterial thrombosis is unclarified. MATERIAL AND METHODS: In a post-hoc analysis of a …